Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues
1Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7295, USA.
Abstract:
p21 and p16, first identified as two small molecular weight proteins in CDK and cyclin immunocomplexes, represent two distinct families constituting a total of seven CDK inhibitors in mammalian cells. The physiological functions of these genes are believed to be broadly involved in connecting various cellular pathways to cell cycle control. Extensive studies over the past 10 years have led to a fairly clear understanding of their biochemical and cellular mechanisms and have also left some unresolved and controversial issues.
Insights
Cyclin-dependent kinase (CDK) inhibitors p21 and p16 are crucial for cell cycle control. While their mechanisms are understood, some aspects remain controversial.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- p21 and p16 are key proteins identified in CDK and cyclin complexes.
- They represent distinct families of cyclin-dependent kinase (CDK) inhibitors in mammals.
- These proteins are vital for linking cellular pathways to cell cycle regulation.
Purpose of the Study:
- To review the known functions and mechanisms of p21 and p16.
- To highlight the current understanding and remaining controversies surrounding these CDK inhibitors.
Main Methods:
- Literature review of studies on p21 and p16.
- Analysis of biochemical and cellular mechanisms.
- Synthesis of existing research findings.
Main Results:
- p21 and p16 are established as critical regulators of the cell cycle.
- Extensive research has clarified many of their functions and interactions.
- Certain aspects of their roles and regulation continue to be debated.
Conclusions:
- The roles of p21 and p16 in cell cycle control are well-defined but complex.
- Further research is needed to resolve outstanding questions regarding these CDK inhibitors.
More Related Videos
12:26Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
Positive Regulator Molecules
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
